Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Alzheimer's Disease

Free Subscription Articles published in Neurobiol Dis Retrieve available abstracts of 121 articles: HTML format

Single Articles

October 2025
1. WANG Y, Lin J, Qu Y, Ding Y, et al
   Biomarker profile of a Chinese ALS cohort: A comprehensive clinical-biomarkers-imaging analysis.
   Neurobiol Dis. 2025;214:107059.
   PubMed     Abstract available
   
   
   
2. NEU M, Parfentev I, Potts GK, Stoberl N, et al
   A role for the autophagy receptor NBR1 in the degradation of tau aggregates.
   Neurobiol Dis. 2025;214:107060.
   PubMed     Abstract available
   
   
   
3. GIANNELLI S, Eroli F, Loera-Valencia R, Leoni V, et al
   Elevated 24-hydroxycholesterol levels counteract okadaic acid-induced tau hyperphosphorylation and neuronal morphology impairment.
   Neurobiol Dis. 2025;214:107029.
   PubMed     Abstract available
   
   
   September 2025
4. YU Y, Zhou RZ, Nilsson P, Winblad B, et al
   Altered APP trafficking drives amyloidogenic processing in primary neurons from the App(NL-F) knock-in mouse model of Alzheimer's disease.
   Neurobiol Dis. 2025 Sep 28:107129. doi: 10.1016/j.nbd.2025.107129.
   PubMed     Abstract available
   
   
   
5. OLAYINKA OA, O'Neill N, Empawi JA, Bock P, et al
   Single nucleus RNA sequencing unveils relationship between microglia and endothelial cells in mixed Alzheimer's disease and vascular pathology.
   Neurobiol Dis. 2025 Sep 27:107128. doi: 10.1016/j.nbd.2025.107128.
   PubMed     Abstract available
   
   
   
6. HEAVENER KS, Tamucci KA, Lee AJ, Kabra K, et al
   P2RX7 modulates the function of human microglia-like cells and mediates the association of IL18 with Alzheimer's disease traits.
   Neurobiol Dis. 2025 Sep 21:107106. doi: 10.1016/j.nbd.2025.107106.
   PubMed     Abstract available
   
   
   
7. STRINGER CA, Miyasato HKS, Camey KA, Ghadia KA, et al
   Regional differences in astrocytic Aquaporin-4 protein levels and distribution in aging and Alzheimer's disease in down syndrome.
   Neurobiol Dis. 2025 Sep 21:107114. doi: 10.1016/j.nbd.2025.107114.
   PubMed     Abstract available
   
   
   
8. ANTEQUERA D, Vargas T, Ugalde C, Spuch C, et al
   Retraction notice to "Cytoplasmic gelsolin increases mitochondrial activity and reduces Abeta burden in a mouse model of Alzheimer's disease" [Neurobiology of Disease 36 (2009) 42-50].
   Neurobiol Dis. 2025 Sep 11:107088. doi: 10.1016/j.nbd.2025.107088.
   PubMed    
   
   
   
9. ONO K, Noguchi M, Matsumoto Y, Yanase D, et al
   Retraction Notice to "Cerebrospinal fluid of Alzheimer patients promotes beta-amyloid fibril formation in vitro" [Neurobiology of Disease 20 (2005) 233-240].
   Neurobiol Dis. 2025 Sep 11:107087. doi: 10.1016/j.nbd.2025.107087.
   PubMed    
   
   
   
10. KRICK KE, Weekman EM, Johnson SN, Sudduth TL, et al
    Age-related cerebral amyloid angiopathy accumulation in the APPSw mouse model is associated with perivascular inflammation and brain-wide vascular and inflammatory gene and protein changes.
    Neurobiol Dis. 2025;213:107013.
    PubMed     Abstract available
    
    
    August 2025
11. CHEN Z, Bi S, He HL, Qi Z, et al
    Multimodal imaging of glymphatic dysfunction and retinal vascular changes as biomarkers for Alzheimer's disease.
    Neurobiol Dis. 2025 Aug 25:107064. doi: 10.1016/j.nbd.2025.107064.
    PubMed     Abstract available
    
    
    
12. SANTIAGO J, Poceviciute D, Vogel J, Brinkmalm G, et al
    Retinal tau phosphorylation in Alzheimer's disease: A mass spectrometry study.
    Neurobiol Dis. 2025;215:107057.
    PubMed     Abstract available
    
    
    
13. FRIDAY CM, Stephens IO, Smith CT, Lee S, et al
    APOE4 reshapes the lipid droplet proteome and modulates microglial inflammatory responses.
    Neurobiol Dis. 2025;212:106983.
    PubMed     Abstract available
    
    
    July 2025
14. SPENCER B, Schueler A, Sung D, Rissman RA, et al
    Differential roles of human tau isoforms in the modulation of inflammation and development of neuropathology.
    Neurobiol Dis. 2025;211:106942.
    PubMed     Abstract available
    
    
    
15. ZARE MS, Abedpoor N, Hajibabaie F, Walker AK, et al
    Gene co-expression patterns shared between chemobrain and neurodegenerative disease models in rodents.
    Neurobiol Dis. 2025;211:106944.
    PubMed     Abstract available
    
    
    
16. PELAGOTTI V, Plantone D, D'Amico F, Raffa S, et al
    [(18)F]FDG PET metabolic correlates of cerebrospinal fluid TAR DNA-binding protein 43 in prodromal Alzheimer's disease.
    Neurobiol Dis. 2025 Jul 1:107014. doi: 10.1016/j.nbd.2025.107014.
    PubMed     Abstract available
    
    
    June 2025
17. CHEN KS, Noureldein MH, Rigan DM, Hayes JM, et al
    Interneuron transcriptomics reveals pathologic markers of Alzheimer's disease progression.
    Neurobiol Dis. 2025 Jun 25:107012. doi: 10.1016/j.nbd.2025.107012.
    PubMed     Abstract available
    
    
    
18. MORAIS RF, Sousa JM, Koba C, Andres L, et al
    Differential involvement of neurotransmitter pathways in AD, bvFTD and MCI: Whole-brain MRI analysis.
    Neurobiol Dis. 2025;209:106897.
    PubMed     Abstract available
    
    
    May 2025
19. SORIANO-HERRADOR C, Ubeda-Banon I, Villanueva-Anguita P, Saiz-Sanchez D, et al
    The chaperones HSP90AA1, HSP90AB1 and BAG3 are specifically distributed among human hippocampal subfields during different Alzheimer's disease stages.
    Neurobiol Dis. 2025 May 26:106971. doi: 10.1016/j.nbd.2025.106971.
    PubMed     Abstract available
    
    
    
20. BADINA AM, Ceyzeriat K, Amosse Q, Tresh A, et al
    Non-linear microglial, inflammatory and oligodendrocyte dynamics across stages of Alzheimer's disease.
    Neurobiol Dis. 2025;211:106950.
    PubMed     Abstract available
    
    
    
21. CERNOTOVA D, Hruzova K, Tous J, Janca R, et al
    Early social deficits in TgF344-AD rats are accompanied by sex-specific parvalbumin-positive interneuron reduction and altered brain oscillations in the hippocampal CA2.
    Neurobiol Dis. 2025;208:106875.
    PubMed     Abstract available
    
    
    April 2025
22. VAN KRUINING D, Losen M, Dehairs J, Swinnen JV, et al
    Early plasma ceramide and sphingomyelin levels reflect APOE genotype but not familial Alzheimer's disease gene mutations in female 5xFAD mice, with brain-region specific sphingolipid alterations.
    Neurobiol Dis. 2025 Apr 17:106923. doi: 10.1016/j.nbd.2025.106923.
    PubMed     Abstract available
    
    
    
23. JOHNSON CN, Evans MR, Blankenship AE, John CS, et al
    Human skeletal muscle mitochondrial pathways are impacted by a neuropathologic diagnosis of Alzheimer's disease.
    Neurobiol Dis. 2025 Apr 16:106916. doi: 10.1016/j.nbd.2025.106916.
    PubMed     Abstract available
    
    
    
24. SHI J, Zhang M, Hu Y, Liu J, et al
    Differences in transcriptome characteristics and drug repositioning of Alzheimer's disease according to sex.
    Neurobiol Dis. 2025;210:106909.
    PubMed     Abstract available
    
    
    March 2025
25. FATIMA G, Ashiquzzaman A, Kim SS, Kim YR, et al
    Vascular and glymphatic dysfunction as drivers of cognitive impairment in Alzheimer's disease: Insights from computational approaches.
    Neurobiol Dis. 2025 Mar 17:106877. doi: 10.1016/j.nbd.2025.106877.
    PubMed     Abstract available
    
    
    
26. TAKEUCHI LE, Kalia LV, Simmons CA
    Vascular models of Alzheimer's disease: An overview of recent in vitro models of the blood-brain barrier.
    Neurobiol Dis. 2025;208:106864.
    PubMed     Abstract available
    
    
    
27. PINI L, Brusini L, Griffa A, Cruciani F, et al
    Functional dynamic network connectivity differentiates biological patterns in the Alzheimer's disease continuum.
    Neurobiol Dis. 2025 Mar 11:106866. doi: 10.1016/j.nbd.2025.106866.
    PubMed     Abstract available
    
    
    
28. WAN L, Zhong P, Li P, Ren Y, et al
    CRISPR-based epigenetic editing of Gad1 improves synaptic inhibition and cognitive behavior in a Tauopathy mouse model.
    Neurobiol Dis. 2025;206:106826.
    PubMed     Abstract available
    
    
    February 2025
29. VOLLHARDT A, Frolich L, Stockbauer AC, Danek A, et al
    Towards a better diagnosis and treatment of dementia: Identifying common and distinct neuropathological mechanisms in Alzheimer's and vascular dementia.
    Neurobiol Dis. 2025 Feb 23:106845. doi: 10.1016/j.nbd.2025.106845.
    PubMed     Abstract available
    
    
    
30. SUN YR, Lv QK, Liu JY, Wang F, et al
    New perspectives on the glymphatic system and the relationship between glymphatic system and neurodegenerative diseases.
    Neurobiol Dis. 2025;205:106791.
    PubMed     Abstract available
    
    
    
31. NAKANO H, Hikishima S, Mori M, Minamikawa J, et al
    Globular-shaped Abeta oligomers have diverse mechanisms for promoting Abeta aggregations with the facilitation of fibril elongation.
    Neurobiol Dis. 2025;205:106775.
    PubMed     Abstract available
    
    
    January 2025
32. MA X, Prokopenko D, Wang N, Aikawa T, et al
    Alzheimer's disease risk ABCA7 p.A696S variant disturbs the microglial response to amyloid pathology in mice.
    Neurobiol Dis. 2025;206:106813.
    PubMed     Abstract available
    
    
    
33. FAURE LMP, Gauzin S, Lejards C, Rampon C, et al
    Fine social discrimination of siblings in mice: Implications for early detection of Alzheimer's disease.
    Neurobiol Dis. 2025 Jan 13:106799. doi: 10.1016/j.nbd.2025.106799.
    PubMed     Abstract available
    
    
    
34. WANG W, Myers SJ, Ollen-Bittle N, Whitehead SN, et al
    Elevation of ganglioside degradation pathway drives GM2 and GM3 within amyloid plaques in a transgenic mouse model of Alzheimer's disease.
    Neurobiol Dis. 2025 Jan 8:106798. doi: 10.1016/j.nbd.2025.106798.
    PubMed     Abstract available
    
    
    
35. ESCARCEGA RD, M J VK, Kyriakopoulos VE, Ortiz GJ, et al
    Serum metabolome profiling in patients with mild cognitive impairment reveals sex differences in lipid metabolism.
    Neurobiol Dis. 2025;204:106747.
    PubMed     Abstract available
    
    
    November 2024
36. JAHOLKOWSKI P, Bahrami S, Fominykh V, Hindley GFL, et al
    Charting the shared genetic architecture of Alzheimer's disease, cognition, and educational attainment, and associations with brain development.
    Neurobiol Dis. 2024 Nov 26:106750. doi: 10.1016/j.nbd.2024.106750.
    PubMed     Abstract available
    
    
    
37. LIU H, Tan AYS, Mehrabi NF, Turner CP, et al
    Astrocytic proteins involved in regulation of the extracellular environment are increased in the Alzheimer's disease middle temporal gyrus.
    Neurobiol Dis. 2024 Nov 25:106749. doi: 10.1016/j.nbd.2024.106749.
    PubMed     Abstract available
    
    
    
38. LI N, Wang X, Lin R, Yang F, et al
    ANGPTL4-mediated microglial lipid droplet accumulation: Bridging Alzheimer's disease and obesity.
    Neurobiol Dis. 2024 Nov 20:106741. doi: 10.1016/j.nbd.2024.106741.
    PubMed     Abstract available
    
    
    October 2024
39. MARTINEZ-GARDEAZABAL J, Pereira-Castelo G, Moreno-Rodriguez M, Llorente-Ovejero A, et al
    Sphingosine 1-phosphate receptor subtype 1 (S1P(1)) activity in the course of Alzheimer's disease.
    Neurobiol Dis. 2024 Oct 22:106713. doi: 10.1016/j.nbd.2024.106713.
    PubMed     Abstract available
    
    
    
40. TANIGUCHI D, Shimonaka S, Imtiaz A, Elahi M, et al
    Legumain/asparaginyl endopeptidase-resistant tau fibril fold produces corticobasal degeneration-specific C-terminal tau fragment.
    Neurobiol Dis. 2024;201:106686.
    PubMed     Abstract available
    
    
    
41. YAMAGUCHI T, Hamano T, Sada K, Asano R, et al
    Syk inhibitors reduce tau protein phosphorylation and oligomerization.
    Neurobiol Dis. 2024;201:106656.
    PubMed     Abstract available
    
    
    
42. SEKIYA M, Sakakibara Y, Hirota Y, Ito N, et al
    Decreased plasma nicotinamide and altered NAD(+) metabolism in glial cells surrounding Abeta plaques in a mouse model of Alzheimer's disease.
    Neurobiol Dis. 2024 Oct 5:106694. doi: 10.1016/j.nbd.2024.106694.
    PubMed     Abstract available
    
    
    
43. MARMOLEJO-GARZA A, Chatre L, Croteau DL, Herron-Bedoya A, et al
    Nicotinamide riboside modulates the reactive species interactome, bioenergetic status and proteomic landscape in a brain-region-specific manner.
    Neurobiol Dis. 2024;200:106645.
    PubMed     Abstract available
    
    
    September 2024
44. MAGALHAES R, Marques F, Selingue E, Boumezbeur F, et al
    A longitudinal MRI analysis reveals altered brain connectivity and microstructural changes in a transgenic mouse model of Alzheimer's disease.
    Neurobiol Dis. 2024 Sep 23:106679. doi: 10.1016/j.nbd.2024.106679.
    PubMed     Abstract available
    
    
    
45. CROCKETT RA, Casselton C, Howard TM, Wilkins KB, et al
    Lateral thinking: Neurodegeneration of the cortical cholinergic system in Alzheimer's disease.
    Neurobiol Dis. 2024;201:106677.
    PubMed     Abstract available
    
    
    
46. ZHUO L, Pang K, Dai J, Wu B, et al
    The neurophysiological mechanisms of medial prefrontal-perirhinal cortex circuit mediating temporal order memory decline in early stage of AD rats.
    Neurobiol Dis. 2024;199:106584.
    PubMed     Abstract available
    
    
    August 2024
47. DOUCETTE L, Turnbill V, Carlin K, Cavanagh A, et al
    Neocortical cholinergic pathology after neonatal brain injury is increased by Alzheimer's disease-related genes in mice.
    Neurobiol Dis. 2024 Aug 5:106629. doi: 10.1016/j.nbd.2024.106629.
    PubMed     Abstract available
    
    
    
48. CEYZERIAT K, Badina AM, Petrelli F, Montessuit S, et al
    Inhibition of the mitochondrial pyruvate carrier in astrocytes reduces amyloid and tau accumulation in the 3xTgAD mouse model of Alzheimer's disease.
    Neurobiol Dis. 2024;200:106623.
    PubMed     Abstract available
    
    
    July 2024
49. LOPEZ-CERDAN A, Andreu Z, Hidalgo MR, Soler-Saez I, et al
    An integrated approach to identifying sex-specific genes, transcription factors, and pathways relevant to Alzheimer's disease.
    Neurobiol Dis. 2024;199:106605.
    PubMed     Abstract available
    
    
    
50. BUCHANAN RA, Wang Y, May JM, Harrison FE, et al
    Ascorbate insufficiency disrupts glutamatergic signaling and alters electroencephalogram phenotypes in a mouse model of Alzheimer's disease.
    Neurobiol Dis. 2024 Jul 12:106602. doi: 10.1016/j.nbd.2024.106602.
    PubMed     Abstract available
    
    
    June 2024
51. LIZAMA BN, North HA, Pandey K, Williams C, et al
    An interim exploratory proteomics biomarker analysis of a phase 2 clinical trial to assess the impact of CT1812 in Alzheimer's disease.
    Neurobiol Dis. 2024 Jun 22:106575. doi: 10.1016/j.nbd.2024.106575.
    PubMed     Abstract available
    
    
    
52. CHANDRASHEKAR DV, Roules GC, Jagadeesan N, Panchal UR, et al
    Hepatic LRP-1 plays an important role in amyloidosis in Alzheimer's disease mice: Potential role in chronic heavy alcohol feeding.
    Neurobiol Dis. 2024 Jun 15:106570. doi: 10.1016/j.nbd.2024.106570.
    PubMed     Abstract available
    
    
    May 2024
53. PAIVA I, Seguin J, Grgurina I, Singh AK, et al
    Dysregulated expression of cholesterol biosynthetic genes in Alzheimer's disease alters epigenomic signatures of hippocampal neurons.
    Neurobiol Dis. 2024 May 22:106538. doi: 10.1016/j.nbd.2024.106538.
    PubMed     Abstract available
    
    
    
54. CANET G, Gratuze M, Zussy C, Bouali ML, et al
    Age-dependent impact of streptozotocin on metabolic endpoints and Alzheimer's disease pathologies in 3xTg-AD mice.
    Neurobiol Dis. 2024 May 9:106526. doi: 10.1016/j.nbd.2024.106526.
    PubMed     Abstract available
    
    
    
55. XIE B, Yang S, Hao Y, Sun Y, et al
    Impaired olfactory identification in dementia-free individuals is associated with the functional abnormality of the precuneus.
    Neurobiol Dis. 2024;194:106483.
    PubMed     Abstract available
    
    
    April 2024
56. RODRIGUES MES, Bolen ML, Blackmer-Raynolds L, Schwartz N, et al
    Diet-induced metabolic and immune impairments are sex-specifically modulated by soluble TNF signaling in the 5xFAD mouse model of Alzheimer's disease.
    Neurobiol Dis. 2024 Apr 24:106511. doi: 10.1016/j.nbd.2024.106511.
    PubMed     Abstract available
    
    
    
57. LEMCHE E, Killick R, Mitchell J, Caton PW, et al
    Molecular mechanisms linking type 2 diabetes mellitus and late-onset Alzheimer's disease: A systematic review and qualitative meta-analysis.
    Neurobiol Dis. 2024;196:106485.
    PubMed     Abstract available
    
    
    
58. TONG B, Ba Y, Li Z, Yang C, et al
    Targeting dysregulated lipid metabolism for the treatment of Alzheimer's disease and Parkinson's disease: Current advancements and future prospects.
    Neurobiol Dis. 2024 Apr 18:106505. doi: 10.1016/j.nbd.2024.106505.
    PubMed     Abstract available
    
    
    
59. SCHRAEN-MASCHKE S, Duhamel A, Vidal JS, Ramdane N, et al
    The free plasma amyloid Abeta(1)(-)(42)/Abeta(1)(-)(40) ratio predicts conversion to dementia for subjects with mild cognitive impairment with performance equivalent to that of the total plasma Abeta(1)(-)(42)/Abeta(1)(-)(40) ratio. The BALTAZAR study.
    Neurobiol Dis. 2024;193:106459.
    PubMed     Abstract available
    
    
    
60. JIAO LL, Dong HL, Liu MM, Wu PL, et al
    The potential roles of salivary biomarkers in neurodegenerative diseases.
    Neurobiol Dis. 2024;193:106442.
    PubMed     Abstract available
    
    
    
61. JADHAV VS, Stair JG, Eck RJ, Smukowski SN, et al
    Transcriptomic evaluation of tau and TDP-43 synergism shows tauopathy predominance and reveals potential modulating targets.
    Neurobiol Dis. 2024;193:106441.
    PubMed     Abstract available
    
    
    March 2024
62. BONIFAZI G, Luchena C, Gaminde-Blasco A, Ortiz-Sanz C, et al
    A nonlinear meccano for Alzheimer's emergence by amyloid beta-mediated glutamatergic hyperactivity.
    Neurobiol Dis. 2024 Mar 15:106473. doi: 10.1016/j.nbd.2024.106473.
    PubMed     Abstract available
    
    
    
63. YAMASHIRO K, Takabayashi K, Kamagata K, Nishimoto Y, et al
    Free water in gray matter linked to gut microbiota changes with decreased butyrate producers in Alzheimer's disease and mild cognitive impairment.
    Neurobiol Dis. 2024 Mar 5:106464. doi: 10.1016/j.nbd.2024.106464.
    PubMed     Abstract available
    
    
    
64. ZENG J, Liao Z, Yang H, Wang Q, et al
    T cell infiltration mediates neurodegeneration and cognitive decline in Alzheimer's disease.
    Neurobiol Dis. 2024;193:106461.
    PubMed     Abstract available
    
    
    
65. TATO-FERNANDEZ C, Ekblad LL, Pietila E, Saunavaara V, et al
    Cognitively healthy APOE4/4 carriers show white matter impairment associated with serum NfL and amyloid-PET.
    Neurobiol Dis. 2024;192:106439.
    PubMed     Abstract available
    
    
    
66. LONG DM, Cravetchi O, Chow ES, Allen C, et al
    The amyloid precursor protein intracellular domain induces sleep disruptions and its nuclear localization fluctuates in circadian pacemaker neurons in Drosophila and mice.
    Neurobiol Dis. 2024;192:106429.
    PubMed     Abstract available
    
    
    February 2024
67. KATSUMATA Y, Wu X, Aung KZ, Gauthreaux K, et al
    Pathologic correlates of aging-related tau astrogliopathy: ARTAG is associated with LATE-NC and cerebrovascular pathologies, but not with ADNC.
    Neurobiol Dis. 2024;191:106412.
    PubMed     Abstract available
    
    
    January 2024
68. KOURTI M, Metaxas A
    A systematic review and meta-analysis of tau phosphorylation in mouse models of familial Alzheimer's disease.
    Neurobiol Dis. 2024 Jan 31:106427. doi: 10.1016/j.nbd.2024.106427.
    PubMed     Abstract available
    
    
    
69. IVANOVA M, Belaya I, Kucharikova N, de Sousa Maciel I, et al
    Upregulation of Integrin beta-3 in astrocytes upon Alzheimer's disease progression in the 5xFAD mouse model.
    Neurobiol Dis. 2024;191:106410.
    PubMed     Abstract available
    
    
    
70. GHARPURE M, Vyavahare S, Ahluwalia P, Gupta SK, et al
    Alterations in Alzheimer's disease microglia transcriptome might be involved in bone pathophysiology.
    Neurobiol Dis. 2024;191:106404.
    PubMed     Abstract available
    
    
    
71. PIETILA E, Snellman A, Tuisku J, Helin S, et al
    Midlife insulin resistance, APOE genotype, and change in late-life brain beta-amyloid accumulation - A 5-year follow-up [(11)C]PIB-PET study.
    Neurobiol Dis. 2024;190:106385.
    PubMed     Abstract available
    
    
    December 2023
72. ZHANG T, Dolga AM, Eisel ULM, Schmidt M, et al
    Novel crosstalk mechanisms between GluA3 and Epac2 in synaptic plasticity and memory in Alzheimer's disease.
    Neurobiol Dis. 2023 Dec 22:106389. doi: 10.1016/j.nbd.2023.106389.
    PubMed     Abstract available
    
    
    
73. KOPCANOVA M, Tait L, Donoghue T, Stothart G, et al
    Resting-state EEG signatures of Alzheimer's disease are driven by periodic but not aperiodic changes.
    Neurobiol Dis. 2023 Dec 17:106380. doi: 10.1016/j.nbd.2023.106380.
    PubMed     Abstract available
    
    
    
74. LIANG K, Li X, Guo Q, Ma J, et al
    Structural changes in the retina and serum HMGB1 levels are associated with decreased cognitive function in patients with Parkinson's disease.
    Neurobiol Dis. 2023;190:106379.
    PubMed     Abstract available
    
    
    
75. HANERT A, Schonfeld R, Weber FD, Nowak A, et al
    Reduced overnight memory consolidation and associated alterations in sleep spindles and slow oscillations in early Alzheimer's disease.
    Neurobiol Dis. 2023 Dec 14:106378. doi: 10.1016/j.nbd.2023.106378.
    PubMed     Abstract available
    
    
    
76. TIMSINA J, Ali M, Do A, Wang L, et al
    Harmonization of CSF and imaging biomarkers in Alzheimer's disease: Need and practical applications for genetics studies and preclinical classification.
    Neurobiol Dis. 2023;190:106373.
    PubMed     Abstract available
    
    
    November 2023
77. NAJAR J, Thorvaldsson V, Kern S, Skoog J, et al
    Polygenic risk scores for Alzheimer's disease in relation to cognitive change: A representative sample from the general population followed over 16 years.
    Neurobiol Dis. 2023;189:106357.
    PubMed     Abstract available
    
    
    
78. WOJDALA AL, Bellomo G, Gaetani L, Toja A, et al
    Trajectories of CSF and plasma biomarkers across Alzheimer's disease continuum: disease staging by NF-L, p-tau181, and GFAP.
    Neurobiol Dis. 2023;189:106356.
    PubMed     Abstract available
    
    
    
79. LI K, Luo X, Zeng Q, Liu X, et al
    Gray matter structural covariance networks patterns associated with autopsy-confirmed LATE-NC compared to Alzheimer's disease pathology.
    Neurobiol Dis. 2023;189:106354.
    PubMed     Abstract available
    
    
    October 2023
80. GAUTIER MK, Kelley CM, Lee SH, Alldred MJ, et al
    Maternal choline supplementation protects against age-associated cholinergic and GABAergic basal forebrain neuron degeneration in the Ts65Dn mouse model of down syndrome and Alzheimer's disease.
    Neurobiol Dis. 2023 Oct 25:106332. doi: 10.1016/j.nbd.2023.106332.
    PubMed     Abstract available
    
    
    
81. HIGGINBOTHAM L, Carter EK, Dammer EB, Haque RU, et al
    Unbiased classification of the elderly human brain proteome resolves distinct clinical and pathophysiological subtypes of cognitive impairment.
    Neurobiol Dis. 2023;186:106286.
    PubMed     Abstract available
    
    
    September 2023
82. BOTELLO-MARABOTTO M, Martinez-Bisbal MC, Calero M, Bernardos A, et al
    Non-invasive biomarkers for mild cognitive impairment and Alzheimer's disease.
    Neurobiol Dis. 2023 Sep 26:106312. doi: 10.1016/j.nbd.2023.106312.
    PubMed     Abstract available
    
    
    
83. CAO E, Ma D, Nayak S, Duong TQ, et al
    Deep learning combining FDG-PET and neurocognitive data accurately predicts MCI conversion to Alzheimer's dementia 3-year post MCI diagnosis.
    Neurobiol Dis. 2023 Sep 26:106310. doi: 10.1016/j.nbd.2023.106310.
    PubMed     Abstract available
    
    
    
84. ISRAEL LL, Braubach O, Shatalova ES, Chepurna O, et al
    Exposure to environmental airborne particulate matter caused wide-ranged transcriptional changes and accelerated Alzheimer's-related pathology: A mouse study.
    Neurobiol Dis. 2023;187:106307.
    PubMed     Abstract available
    
    
    
85. MEDINA-VERA D, Zambrana-Infantes EN, Lopez-Gambero AJ, Verheul-Campos J, et al
    Transcending the amyloid-beta dominance paradigm in Alzheimer's disease: An exploration of behavioural, metabolic, and gut microbiota phenotypes in 5xFAD mice.
    Neurobiol Dis. 2023 Sep 15:106295. doi: 10.1016/j.nbd.2023.106295.
    PubMed     Abstract available
    
    
    
86. LISGARAS CP, Scharfman HE
    Interictal spikes in Alzheimer's disease: Preclinical evidence for dominance of the dentate gyrus and cholinergic control by medial septum.
    Neurobiol Dis. 2023 Sep 13:106294. doi: 10.1016/j.nbd.2023.106294.
    PubMed     Abstract available
    
    
    
87. LEITAO ADG, Ahammad RU, Spencer B, Wu C, et al
    Novel systemic delivery of a peptide-conjugated antisense oligonucleotide to reduce alpha-synuclein in a mouse model of Alzheimer's disease.
    Neurobiol Dis. 2023;186:106285.
    PubMed     Abstract available
    
    
    
88. SIGNAL B, Perez Suarez TG, Taberlay PC, Woodhouse A, et al
    Cellular specificity is key to deciphering epigenetic changes underlying Alzheimer's disease.
    Neurobiol Dis. 2023;186:106284.
    PubMed     Abstract available
    
    
    
89. MEEHAN CE, Schantell M, Springer SD, Wiesman AI, et al
    Movement-related beta and gamma oscillations indicate parallels and disparities between Alzheimer's disease and HIV-associated neurocognitive disorder.
    Neurobiol Dis. 2023;186:106283.
    PubMed     Abstract available
    
    
    August 2023
90. GIUFFRE GM, Quaranta D, Costantini EM, Citro S, et al
    Cerebrospinal fluid neurofilament light chain and total-tau as biomarkers of neurodegeneration in Alzheimer's disease and frontotemporal dementia.
    Neurobiol Dis. 2023 Aug 29:106267. doi: 10.1016/j.nbd.2023.106267.
    PubMed     Abstract available
    
    
    
91. DAS M, Mao W, Voskobiynyk Y, Necula D, et al
    Alzheimer risk-increasing TREM2 variant causes aberrant cortical synapse density and promotes network hyperexcitability in mouse models.
    Neurobiol Dis. 2023 Aug 15:106263. doi: 10.1016/j.nbd.2023.106263.
    PubMed     Abstract available
    
    
    
92. ARMSTRONG MJ, Jin Y, Vattathil SM, Huang Y, et al
    Role of TET1-mediated epigenetic modulation in Alzheimer's disease.
    Neurobiol Dis. 2023;185:106257.
    PubMed     Abstract available
    
    
    
93. EMMERSON JT, Do Carmo S, Liu Y, Shalhoub A, et al
    Progressive human-like tauopathy with downstream neurodegeneration and neurovascular compromise in a transgenic rat model.
    Neurobiol Dis. 2023;184:106227.
    PubMed     Abstract available
    
    
    
94. DUMONT M, Agostinis A, Singh K, Swan E, et al
    Sex representation in neurodegenerative and psychiatric disorders' preclinical and clinical studies.
    Neurobiol Dis. 2023;184:106214.
    PubMed     Abstract available
    
    
    July 2023
95. TROJAN E, Curzytek K, Cieslik P, Wieronska JM, et al
    Prenatal stress aggravates age-dependent cognitive decline, insulin signaling dysfunction, and the pro-inflammatory response in the APP(NL-F/NL-F) mouse model of Alzheimer's disease.
    Neurobiol Dis. 2023 Jul 6:106219. doi: 10.1016/j.nbd.2023.106219.
    PubMed     Abstract available
    
    
    
96. LEGAZ A, Prado P, Moguilner S, Baez S, et al
    Social and non-social working memory in neurodegeneration.
    Neurobiol Dis. 2023;183:106171.
    PubMed     Abstract available
    
    
    June 2023
97. MOWRY FE, Espejo-Porras F, Shijie J, Quadri Z, et al
    Chronic nSMase inhibition suppresses neuronal exosome spreading and sex-specifically attenuates amyloid pathology in APP knock-in Alzheimer's disease mice.
    Neurobiol Dis. 2023 Jun 24:106213. doi: 10.1016/j.nbd.2023.106213.
    PubMed     Abstract available
    
    
    
98. SUN Y, Bae YE, Zhu J, Zhang Z, et al
    A splicing transcriptome-wide association study identifies novel altered splicing for Alzheimer's disease susceptibility.
    Neurobiol Dis. 2023 Jun 22:106209. doi: 10.1016/j.nbd.2023.106209.
    PubMed     Abstract available
    
    
    
99. DI MAIO A, Nuzzo T, Gilio L, Serra M, et al
    Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patients.
    Neurobiol Dis. 2023 Jun 17:106203. doi: 10.1016/j.nbd.2023.106203.
    PubMed     Abstract available
    
    
    
100. BRADY ES, Griffiths J, Andrianova L, Bielska MH, et al
     Alterations to parvalbumin-expressing interneuron function and associated network oscillations in the hippocampal - medial prefrontal cortex circuit during natural sleep in App(NL-G-F/NL-G-F) mice.
     Neurobiol Dis. 2023;182:106151.
     PubMed     Abstract available
     
     
     
101. FRANKLIN ZJ, Croce L, Dekeryte R, Delibegovic M, et al
     BACE cleavage of APP does not drive the diabetic phenotype of PLB4 mice.
     Neurobiol Dis. 2023;182:106142.
     PubMed     Abstract available
     
     
     
102. ZOREC R, Vardjan N
     Adrenergic regulation of astroglial aerobic glycolysis and lipid metabolism: Towards a noradrenergic hypothesis of neurodegeneration.
     Neurobiol Dis. 2023;182:106132.
     PubMed     Abstract available
     
     
     
103. LUTSHUMBA J, Wilcock D, Monson NL, Stowe AM, et al
     Sex-based differences in effector cells of the adaptive immune system during Alzheimer's disease and related dementias.
     Neurobiol Dis. 2023 Jun 15:106202. doi: 10.1016/j.nbd.2023.106202.
     PubMed     Abstract available
     
     
     
104. PATEL PJ, Ren Y, Yan Z
     Epigenomic analysis of Alzheimer's disease brains reveals diminished CTCF binding on genes involved in synaptic organization.
     Neurobiol Dis. 2023 Jun 9:106192. doi: 10.1016/j.nbd.2023.106192.
     PubMed     Abstract available
     
     
     
105. FOMINYKH V, Shadrin AA, Jaholkowski PP, Bahrami S, et al
     Shared genetic loci between Alzheimer's disease and multiple sclerosis: Crossroads between neurodegeneration and immune system.
     Neurobiol Dis. 2023 Jun 5:106174. doi: 10.1016/j.nbd.2023.106174.
     PubMed     Abstract available
     
     
     
106. DE FLORES R, Demeilliez-Servouin S, Kuhn E, Chauveau L, et al
     Respective influence of beta-amyloid and APOE epsilon4 genotype on medial temporal lobe subregions in cognitively unimpaired older adults.
     Neurobiol Dis. 2023;181:106127.
     PubMed     Abstract available
     
     
     
107. DUWAT C, Leal P, Vautheny A, Auregan G, et al
     Development of an AAV-based model of tauopathy targeting retinal ganglion cells and the mouse visual pathway to study the role of microglia in Tau pathology.
     Neurobiol Dis. 2023;181:106116.
     PubMed     Abstract available
     
     
     
108. PEDERSEN TJ, Keil SA, Han W, Wang MX, et al
     The effect of aquaporin-4 mis-localization on Abeta deposition in mice.
     Neurobiol Dis. 2023;181:106100.
     PubMed     Abstract available
     
     
     May 2023
109. SNELLMAN A, Ekblad LL, Ashton NJ, Karikari TK, et al
     Head-to-head comparison of plasma p-tau181, p-tau231 and glial fibrillary acidic protein in clinically unimpaired elderly with three levels of APOE4-related risk for Alzheimer's disease.
     Neurobiol Dis. 2023 May 31:106175. doi: 10.1016/j.nbd.2023.106175.
     PubMed     Abstract available
     
     
     
110. MUSAEUS CS, Frederiksen KS, Andersen BB, Hogh P, et al
     Detection of subclinical epileptiform discharges in Alzheimer's disease using long-term outpatient EEG monitoring.
     Neurobiol Dis. 2023 May 15:106149. doi: 10.1016/j.nbd.2023.106149.
     PubMed     Abstract available
     
     
     
111. MABROUK R, Miettinen PO, Tanila H
     Most dystrophic neurites in the common 5xFAD Alzheimer mouse model originate from axon terminals.
     Neurobiol Dis. 2023;182:106150.
     PubMed     Abstract available
     
     
     
112. CHEN Z, Reynolds RH, Pardinas AF, Gagliano Taliun SA, et al
     The contribution of Neanderthal introgression and natural selection to neurodegenerative diseases.
     Neurobiol Dis. 2023;180:106082.
     PubMed     Abstract available
     
     
     
113. VARBANOV H, Jia S, Kochlamazashvili G, Bhattacharya S, et al
     Rescue of synaptic and cognitive functions in polysialic acid-deficient mice and dementia models by short polysialic acid fragments.
     Neurobiol Dis. 2023;180:106079.
     PubMed     Abstract available
     
     
     April 2023
114. WITTRAHM R, Takalo M, Kuulasmaa T, Makinen PM, et al
     Protective Alzheimer's disease-associated APP A673T variant predominantly decreases sAPPbeta levels in cerebrospinal fluid and 2D/3D cell culture models.
     Neurobiol Dis. 2023;182:106140.
     PubMed     Abstract available
     
     
     
115. SHIN YJ, Evitts KM, Jin S, Howard C, et al
     Amyloid beta peptides (Abeta) from Alzheimer's disease neuronal secretome induce endothelial activation in a human cerebral microvessel model.
     Neurobiol Dis. 2023 Apr 14:106125. doi: 10.1016/j.nbd.2023.106125.
     PubMed     Abstract available
     
     
     
116. LI T, Li D, Wei Q, Shi M, et al
     Dissecting the neurovascular unit in physiology and Alzheimer's disease: Functions, imaging tools and genetic mouse models.
     Neurobiol Dis. 2023 Apr 4:106114. doi: 10.1016/j.nbd.2023.106114.
     PubMed     Abstract available
     
     
     
117. GRECO GA, Rock M, Amontree M, Lanfranco MF, et al
     CCR5 deficiency normalizes TIMP levels, working memory, and gamma oscillation power in APOE4 targeted replacement mice.
     Neurobiol Dis. 2023;179:106057.
     PubMed     Abstract available
     
     
     
118. PRADO P, Moguilner S, Mejia JA, Sainz-Ballesteros A, et al
     Source space connectomics of neurodegeneration: One-metric approach does not fit all.
     Neurobiol Dis. 2023;179:106047.
     PubMed     Abstract available
     
     
     
119. AFROZ T, Chevalier E, Audrain M, Dumayne C, et al
     Immunotherapy targeting the C-terminal domain of TDP-43 decreases neuropathology and confers neuroprotection in mouse models of ALS/FTD.
     Neurobiol Dis. 2023;179:106050.
     PubMed     Abstract available
     
     
     March 2023
120. RIZZELLO E, Pimpinella D, Pignataro A, Titta G, et al
     Lamotrigine rescues neuronal alterations and prevents seizure-induced memory decline in an Alzheimer's disease mouse model.
     Neurobiol Dis. 2023 Mar 29:106106. doi: 10.1016/j.nbd.2023.106106.
     PubMed     Abstract available
     
     
     
121. TEIPEL S, Grothe MJ
     MRI-based basal forebrain atrophy and volumetric signatures associated with limbic TDP-43 compared to Alzheimer's disease pathology.
     Neurobiol Dis. 2023;180:106070.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.